PhD THESIS Epigenetic mechanisms involved in stem cell differentiation

Similar documents
CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells

Epigenetics. Lyle Armstrong. UJ Taylor & Francis Group. f'ci Garland Science NEW YORK AND LONDON

R. Piazza (MD, PhD), Dept. of Medicine and Surgery, University of Milano-Bicocca EPIGENETICS

Histones modifications and variants

Are you the way you are because of the

HDAC1 Inhibitor Screening Assay Kit

Epigenetics Armstrong_Prelims.indd 1 04/11/2013 3:28 pm

Tissue repair. (3&4 of 4)

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest

Histone Deacetylase (HDAC) Inhibitors Down-Regulate Endothelial Lineage Commitment of Umbilical Cord Blood Derived Endothelial Progenitor Cells

Nasser Aghdami MD., PhD

Epigenetics: The Future of Psychology & Neuroscience. Richard E. Brown Psychology Department Dalhousie University Halifax, NS, B3H 4J1

Host cell activation

Role of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies. Traditional Hypothesis Stress

Epigenetics q&more 01.11

Angiogenesis in Human Development. Vascular Development

PhD THESIS FACTORS MODULATING THE THERAPEUTIC POTENTIAL OF ENDOTHELIAL PROGENITOR CELLS FOR NEOVASCULARIZATION OF ISCHEMIC TISSUES

Eukaryotic transcription (III)

Not IN Our Genes - A Different Kind of Inheritance.! Christopher Phiel, Ph.D. University of Colorado Denver Mini-STEM School February 4, 2014

Hox genes. Discovered in Drosophila in 1923 by Bridges and Morgan Antennapaedia complex ANT-C Bithorax complex BX-C

HOMEWORK RUBRICS MECHANOTRANSDUCTION UNIT: HOMEWORK #1 (20 pts towards your grade)

Stem cells in endometriosis: pathogenetic factors and target for new medical treatments? Alberto Revelli MD PhD

Gene Expression DNA RNA. Protein. Metabolites, stress, environment

Genetics and Genomics in Medicine Chapter 6 Questions

Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression. Chromatin Array of nuc

SDF-1/CXCR4 Axis on Endothelial Progenitor Cells Regulates Bone Fracture Healing

Rino Ragno Rome Center for Molecular Design Department of Chemistry and Phamaceutical Technology Faculty of Pharmacy and Medicine

Journal Club Semmler Lorenz

Transcription and chromatin. General Transcription Factors + Promoter-specific factors + Co-activators

Tissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science

Comparative effect of Various HDAC-inhibitors in-vitro on T- Cell Lymphoma cell lines alone and in combination with conventional anti-cancer drugs

ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU. PhD THESIS Summary

September 20, Submitted electronically to: Cc: To Whom It May Concern:

International Graduate Research Programme in Cardiovascular Science

Jayanti Tokas 1, Puneet Tokas 2, Shailini Jain 3 and Hariom Yadav 3

Stem Cell Epigenetics

HDAC1 Inhibitor Screening Assay Kit

Post-translational modifications of proteins in gene regulation under hypoxic conditions

Chromatin Structure & Gene activity part 2

Biochemical Determinants Governing Redox Regulated Changes in Gene Expression and Chromatin Structure

Focus on biological identity of endothelial progenitors cells

Mechanisms of Gene Regulation and Signal! Transduction in Hypoxia!

Prokaryotes and eukaryotes alter gene expression in response to their changing environment

Cancer as a disease of development; Developmental therapies: Anti- Angiogenesis; Stem cells and tissue regeneration.

Transcription Regulation And Gene Expression in Eukaryotes Cycle G2 (lecture 13709) FS 2014 P Matthias & RG Clerc

Cluster Dendrogram. dist(cor(na.omit(tss.exprs.chip[, c(1:10, 24, 27, 30, 48:50, dist(cor(na.omit(tss.exprs.chip[, c(1:99, 103, 104, 109, 110,

Endothelial Injury and Repair as a Working Paradigm

Reprogramming through micrornas Stefanie Dimmeler

Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System

EpiQuik Circulating Acetyl Histone H3K18 ELISA Kit (Colorimetric)

Ricardo E. Colberg, MD, RMSK. PM&R Sports Medicine Physician Andrews Sports Medicine and Orthopedic Center American Sports Medicine Institute

Hox Gene Expression in mouse Embryonic Stem Cells

Epigenetic Mechanisms

Inflammatory Cells and Metastasis

Ch. 18 Regulation of Gene Expression

Cancer Problems in Indonesia

Journal Club WS 2012/13 Stefanie Nickl

Blood 101 Introduction Blood and Marrow & Overview of Bone Marrow Failure Diseases. Dr. M. Sabloff October 16 th 2010

Disorders of Cell Growth & Neoplasia. Lecture 4 Molecular basis of cancer

Culture and Characterization of Endothelial Colony Forming Cells from Peripheral Blood, Bone Marrow, and Umbilical Cord Blood of Horses

I) Development: tissue differentiation and timing II) Whole Chromosome Regulation

Controlling Epithelial to Mesenchymal Transition through Acetylation of Histone H2BK5

Structure and Function of Fusion Gene Products in. Childhood Acute Leukemia

Lecture 8. Eukaryotic gene regulation: post translational modifications of histones

Mesenchymal progenitor cells in intramuscular connective tissue development

The Angio-Ready Assay System

Signaling Vascular Morphogenesis and Maintenance

REGENERATIVE MEDICINE

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

HDAC Cell-Based Activity Assay Kit

The Role of Smoking in Cocaine. Addiction

HDAC Cell-Based Activity Assay Kit

Stem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford

Transcriptional and Epigenetic Mechanisms of Addiction

In vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG)

SCIENTIFIC PROGRAM. 30 th Annual International Asilomar Chromatin & Chromosomes Conference

Hematopoiesis. - Process of generation of mature blood cells. - Daily turnover of blood cells (70 kg human)

Overview: Conducting the Genetic Orchestra Prokaryotes and eukaryotes alter gene expression in response to their changing environment

INTERACTION DRUG BODY

Epigenetic Inheritance

Chromatin-Based Regulation of Gene Expression

Eukaryotic Gene Regulation

Cellular Physiology and Biochemistry

stem cell products Basement Membrane Matrix Products Rat Mesenchymal Stem Cell Growth and Differentiation Products

EUROPEAN SOCIETY OF ENDODONTOLOGY ANNUAL RESEARCH GRANT 2012

VWF other roles than hemostasis. Summary 1: VWF & hemostasis synthesis 11/4/16. Structure/function relationship & functions kDa.

EMT: Epithelial Mesenchimal Transition

gliomas. Fetal brain expected who each low-

Macrophages form functional vascular mimicry channels in vivo. SI Figures and Legend

9 th TRR81 PhD Minisymposium Kinases as regulators of chromatin structure and transcription

Production of Exosomes in a Hollow Fiber Bioreactor

Histone modifications in kidney disease

Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice

Lecture 10. Eukaryotic gene regulation: chromatin remodelling

Regulation of Gene Expression in Eukaryotes

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

Computational Analysis of UHT Sequences Histone modifications, CAGE, RNA-Seq

EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS

Epigenetic mechanisms behind cellular sensitivity to DNA damage

Transcription:

Romanian Academy Institute of Cellular Biology and Pathology "Nicolae Simionescu" PhD THESIS Epigenetic mechanisms involved in stem cell differentiation Coordinator: Acad. Maya Simionescu PhD Student: Florin Iordache Bucharest 2013

Table of contents INTRODUCTION PART I. CURRENT STATE OF KNOWLEDGE CHAPTER I.1 Endothelial progenitor cells...6 I.1.1 Definition and characteristics of stem cells...6 I.1.2 Classification and types of stem cells...8 I.1.3 Umbilical cord blood derived endothelial progenitor cells...18 I.1.4 Clinical applications of endothelial progenitor cells in cardiovascular pathology...22 CHAPTER I.2 Epigenetic mechanisms and their role in stem cell differentiation...26 I.2.1 Definition and characteristics of epigenetic modifications...31 I.2.2 Classification and types of epigenetic modifications...32 I.2.2.1 DNA methylation...32 I.2.2.2 Histone modifications...34 a. Methylation b. Acetylation c. Phosphorylation d. Sumoilation e. Ubiquitinilation f. Proline isomerization g. ADP-ribosylation h. Deimination I.2.2.3 microarn...47

CHAPTER I.3 Histone acetylation mechanisms and their role in stem cell differentiation...57 I.3.1 Definition and characteristics of acetylation...57 I.3.2 Classification of enzymes involved in the acetylation:...59 I.3.2.1 Histon-acetyltransferase (HAT)...60 I.3.2.2 Histon-deacetylase (HDAC)...65 I.3.3 Mechanisms of action in acetylation of non-histone and histone protein...72 I.3.4 The role of histone acetylation in stem cells differentiation...78 PART II. ORIGINAL CONTRIBUTIONS...84 II.1 Aim and Objectives...84 II.2 Materials and Methods...86 II.3 Results and Discussion...106 II.3.1 Isolation and characterization of endothelial progenitor cells from umbilical cord blood...106 II.3.2 Investigation of histone acetylation levels in endothelial progenitor cells...119 II.3.3 Effect of histone acetylation in differentiation of endothelial progenitor cells...125 II.3.4 Analysis of acetylation of some transcription factors involved in cardiovascular morphogenesis...129 II.3.5 The role of acetylation in in vitro neovascularization...131 II. 4. General conclusions...145 References...148 Dissemination of results obtained during PhD...172 Research funding...178

Keywords Acetylation Histone Chromatine Epigenetics Stem cells Endothelial progenitor cells Fetal stem cells Differentiation Neovascularization Cardiovascular diseases

Thesis abstract Importance of the study Understanding the mechanisms which lead to differentiation of stem cells is the primary focus of numerous studies. Accessibility of DNA to transcription factors depends on chromatin structure and its degree of compaction. Recent analysis of epigenetic changes in human and murine stem cells have provided new data on the properties of pluripotency of stem cells and their differentiation capacity. These mechanisms lead to a hierarchy of transcription, are mediated by transcription factors and are designed to control gene expression without altering the DNA. Multipotent stem cell capacity decreases with time due to repression of certain genes that presents an epigenetic "signature". Active genes in the stem cells are silent gradually with the passing of their progenitors, and another subset of tissue - specific genes are activated. This progression is achieved by selective expression of transcription factors that recognize and interact with various epigenetic changes in the chromatin. As a result of these events, chromatin becomes accessible for transcription in certain regions, allowing the necessary spatial and temporal control for stem cell differentiation. For example, protein HP1 ( heterochromatin protein 1 ) distribution changes from a dispersed localization in embryonic stem cells to build more concentrated in distinct loci during cell differentiation. Histone acetylation was seen as a phenomenon correlated with an open chromatin conformation that allowed the expression of different genes involved in differentiation. Currently it has been observed that in acetylated state, many genes are repressed and thus differentiation to a specific cell line is blocked, maintaining the pluripotent state. Handling histone deacetylase activity could be a useful tool to generate specific cell populations in order to use them in transplantation. Discovering patterns of acetylation ("acetylation signature ) involved in the differentiation of stem cells to different cell types, opening new opportunities at the interface between chemistry and stem cell biology, and can provide valuable information to improve applications of stem cells in tissue engineering and regenerative medicine. In this context, the aim of the thesis is to investigate the role of histone acetylation in the differentiation of endothelial progenitor cells by analyzing the expression of different genetic markers and transcription factors that regulate the activity of these genes. Also, these studies investigate the effect of endothelial progenitor cells acetylation on the process of in vitro neovascularization.

The thesis is divided into two main parts: Part I - Current state of knowledge and Part II - Original contributions. The first part presents the current state of knowledge and is organized into three sections. Subchapter I present notions about the characteristics and properties of stem cells. In this chapter is presented the cell model used in the thesis, represented by endothelial progenitor cells and their potential clinical applications. Subchapter II makes an overview of the main epigenetic modifications. It describes the mechanisms of action of these modifications and the enzymes involved in their implementation. Also in this section describes the role of epigenetic changes in stem cell differentiation to various cell lines. Subchapter III describes the mechanisms of histone acetylation and their role in stem cell differentiation. This chapter presents the main classes of histone acetyltransferase and histone deacetylases, histone acetylation mechanisms of action and influenceof acetylation in endothelial progenitor cell differentiation. In Part II - "Original Contributions" are presented the results of experiments aimed to investigating the role of histone acetylation in the differentiation of endothelial progenitor cells and in neovascularization in vitro. Chapter II.2 - " Materials and Methods " describes the main materials and techniques used in the experiments, including many molecular and cell biology techniques: Real -Time PCR, Western blot, flow cytometry, transmission electron microscopy and scanning electron microscopy, immunocytochemistry and immunohistochemistry, colorimetric and fluorimetric methods. Chapter II.3 - " Results and discussion " presents the main original results obtained in the studies. Results and discussion Understanding the mechanisms which lead to the differentiation of stem cells is the primary focus of numerous studies. Recent analysis of epigenetic changes in human and murine stem cells have provided new data on the properties of pluripotecy of stem cells and their differentiation capacity. These mechanisms lead to a hierarchy of transcription, are mediated by transcription factors and are designed to control gene expression without altering the DNA. Histone acetylation was seen as a phenomenon correlated with an open chromatin conformation, allowing the expression of various genes involved in differentiation.

Currently it has been observed that in acetylated state, many genes are repressed and thus differentiation to a specific cell line is blocked, maintaining the pluripotent state. In this thesis we have shown that umbilical cord blood contains a rich population of endothelial progenitor cells with an characteristic immunophenotype profile: CD31, CD34, CD133, CD144, CD146, VEGFR2. Molecular analysis of cells obtained from umbilical cord blood showed the presence of genes that are involved in cardiovascular morphogenesis, such as genes for transcription factors GATA2, GATA3, GATA4, and genes that are characteristic of endothelial cells: CD31, VE- cadherin, VEGFR1, VEGFR2, vwf, CXCR4, Tie -2. We have also shown that endothelial progenitor cells have a high capacity of proliferation and migration in comparison with other fetal stem cells types. These cells can uptake acetylated LDL, and Ulex europaeus lectin, can form vascular network, suggesting their potential in angiogenesis and vascular repair. This was confirmed using murine embryonic ventricular sections viable or subjected to ischemia, in which we showed that endothelial progenitor cells have the ability to integrate and form vascular networks. Our results indicated that endothelial progenitor cells forming the vascular structures only on viable murine embryonic ventricular sections, while in the ischemic sections only integrate, which demonstrates a direct cell-to cell communication. The results showed that histone acetylation inhibit the differentiation of endothelial progenitor cells. Inhibitors of deacetylation ( VPA, TSA, BuA ) mentain chromatin in an acetylated state corresponding to a decondensate conformation. Histone deacetylases level was significantly decreased in the presence of these inhibitors and histone H3 acetylated level was increased and these changes are correlated with the expression of differentiation markers involved in endothelial progenitor cells commitment. The molecular biology and immunophenotyping data showes that HDAC inhibitors have inhibited the expression of vwf, VEGFR2, enos, CD117, CD133, CD144, CXCR4 and Tie- 2, while the expression of CD34 and CD45 remains unchanged showing that the histone deacetylases are involved in the differentiation of endothelial progenitor cells. VE-cadherin expression was significantly inhibited both at the mrna and protein level. The mechanism underlying the expression of VE-cadherin may be explained by inability of HoxC6 transcription factor to interact with acetylated histones in order to activate the VE-cadherin promoter. Gene expression of CXCR4, Tie-2 and VEGFR2 significantly decreased after treatment with TSA, the mechanism involved is controlled by Hox transcription factors whose expression is modulated in the presence of these inhibitors. Our results have shown that in the acetylated state HoxD9 expression in endothelial progenitor cells is increased in both gene and protein level.

The process of neovascularization is a complex process involving a series of interconnected steps leading to the formation of new blood vessels when vascular lesions occur in adult bodies. In contrast to angiogenesis, which is the formation of new blood vessels from some pre-existing one, neovascularization takes place via endothelial progenitor cells. These cells are mobilized to migrate, proliferate and differentiate at the target site, under the action of cytokines and the microenvironment. Our results have shown that histone acetylation inhibits neovascularization in vitro, acting in the processes of proliferation, adherence, migration and differentiation of endothelial progenitor cells. Endothelial progenitor cells showed a significantly decreased level of telomerase activity in comparison with the control, suggesting a decrease in cell proliferation. Cell motility assessed using the "wound-healing assay" and cell impedance measurement, showed that HDAC inhibitors decrease cell motility at 24 hours after stimulation. In contrast, chemotaxis of endothelial progenitor cells was increased after treatment with HDAC inhibitors, which can be explained by the maintenance of a circulating progenitor phenotype. In the presence of 3 mm VPA our data showed a significant stimulation of chemotaxis of endothelial progenitor cells to angiopoietin, VEGF and SDF. After proliferation, mobilization, migration and adherence of endothelial progenitor cells to the target situs, the last step consists in organizing their vascular network. We analysed also this step in terms of acetylation. Growing on Matrigel in the presence of HDAC inhibitors endothelial progenitor cells can not form vascular networks. To confirm these results we used other collagen-based matrix. The results indicated that endothelial progenitor cells isolated from umbilical cord blood were able to survive and adhere to the collagen matrix. Moreover, these cells emit extensions, interact with each other and with the matrix, forming in the network structure. In acetylated state, endothelial progenitor cells lose this ability, which demonstrates that acetylation inhibits neovascularization potential of endothelial cells in vitro. Handling histone deacetylase activity could be a useful tool to generate specific cell populations for transplantation. Discovering patterns of acetylation ( "acetylation signature") involved in the differentiation of stem cells to different cell types, opening new opportunities at the interface between chemistry and stem cell biology, and can provide valuable information to improve applications of stem cells in tissue engineering and regenerative medicine.

Number of figures in the first part -32 Number of figures in the original contribution (Part II) 40 Bibliographical notes 251 Papers published in international journal (ISI) 4 Papers published in national journals (CNCSIS B +) 1 Oral communications: 2 Abstracts of papers presented at international scientific meetings 11 Abstracts of papers presented at national conferences 25 Participation in research projects - 2 national, 1 international